IL6 and atrial fibrillation: IL-6 has been reported to be useful as a biomarker predicting the development of AF in a limited group of patients, including patients with coronary artery disease and chronic kidney disease (Marcus et al., 2008; Wu et al., 2013; Amdur et al., 2016).